GANIRELIX
Total Payments
$11,488
Transactions
410
Doctors
187
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $1,885 | 106 | 81 |
| 2018 | $1,282 | 78 | 44 |
| 2017 | $8,322 | 226 | 104 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,564 | 409 | 57.1% |
| Unspecified | $4,925 | 1 | 42.9% |
Payments by Type
General
$6,564
409 transactions
Research
$4,925
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Efficacy of Recombinant FSH,GnRH Antagonist Protocol with and without LH Adjunct and GnRH agonist trigger for Egg Bank Donation. | Merck Sharp & Dohme Corporation | $4,925 | 0 |
Top Doctors Receiving Payments for GANIRELIX
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Mark Amols | — | Mesa, AZ | $4,954 | 3 |
| , MD | Reproductive Endocrinology | Saint Louis, MO | $225.26 | 15 |
| , MD | Reproductive Endocrinology | Saint Louis, MO | $212.81 | 13 |
| , MD | Reproductive Endocrinology | St Louis, MO | $200.50 | 11 |
| , MD | Reproductive Endocrinology | Saint Louis, MO | $175.87 | 11 |
| , MD | Specialist | Saint Louis, MO | $168.24 | 9 |
| , M.D | Reproductive Endocrinology | Indianapolis, IN | $165.87 | 9 |
| , M.D | Reproductive Endocrinology | Columbia, MO | $162.19 | 9 |
| , MD | Reproductive Endocrinology | Saint Louis, MO | $150.92 | 8 |
| , MD | Obstetrics & Gynecology | Columbia, MO | $133.94 | 8 |
| , MD | Obstetrics & Gynecology | Indianapolis, IN | $108.75 | 6 |
| , M.D | Specialist | Chesterfield, MO | $89.53 | 5 |
| , M.D | Reproductive Endocrinology | Glenview, IL | $89.49 | 7 |
| , M.D | Obstetrics & Gynecology | Frisco, TX | $81.24 | 5 |
| , M.D | Reproductive Endocrinology | Naperville, IL | $80.58 | 5 |
| , MD | Reproductive Endocrinology | Newburgh, IN | $75.14 | 4 |
| , M.D | Reproductive Endocrinology | Dallas, TX | $73.31 | 5 |
| , M.D | Reproductive Endocrinology | Glenview, IL | $72.72 | 7 |
| , M.D | Student in an Organized Health Care Education/Training Program | Houston, TX | $70.53 | 4 |
| , MD | Obstetrics & Gynecology | San Antonio, TX | $69.59 | 4 |
| , M.D | Obstetrics & Gynecology | Frisco, TX | $63.29 | 4 |
| , M.D | Obstetrics & Gynecology | Lackland Afb, TX | $63.11 | 6 |
| , M.D | Reproductive Endocrinology | Houston, TX | $62.32 | 4 |
| , M.D | Reproductive Endocrinology | Dallas, TX | $61.47 | 4 |
| , M.D | Reproductive Endocrinology | St Louis, MO | $59.53 | 3 |
Ad
Manufacturing Companies
- Merck Sharp & Dohme Corporation $11,361
- Ferring Pharmaceuticals Inc. $127.23
Product Information
- Type Drug
- Total Payments $11,488
- Total Doctors 187
- Transactions 410
About GANIRELIX
GANIRELIX is a drug associated with $11,488 in payments to 187 healthcare providers, recorded across 410 transactions in the CMS Open Payments database. The primary manufacturer is Merck Sharp & Dohme Corporation.
Payment data is available from 2017 to 2019. In 2019, $1,885 was paid across 106 transactions to 81 doctors.
The most common payment nature for GANIRELIX is "Food and Beverage" ($6,564, 57.1% of total).
GANIRELIX is associated with 1 research study, including "Efficacy of Recombinant FSH,GnRH Antagonist Protocol with and without LH Adjunct and GnRH agonist trigger for Egg Bank Donation." ($4,925).